Restenosis
Friday, 12 April 2002

Organizers

 E. Schröder (Yvoir, Belgium)
C. Hanet (Brussels, Belgium)

Prevention of restenosis after coronary angioplasty

Session I

  
Abstract no
Chair E. Schröder (Yvoir, Belgium)
C. Hanet (Brussels, Belgium)		  
9.30 – 9.55 The clinical impact of restenosis
E. Schröder (Yvoir, Belgium)		  
9.55 – 10.20 Overview of randomized trials on prevention of restenosis by systemic drugs
C. Hanet (Brussels, Belgium)		  
10.20 – 10.45 Stent implantation during PTCA : a first step towards a reduction of restenotic events
V. Legrand (Liège, Belgium)		  
10.45 – 11.15 coffee break  
11.15 – 11.40 Brachytherapy in de novo and restenotic lesions
V. Verine (Genève, Switzerland)		  
11.40 – 12.05 Cytochalasin D inhibits neointimal formation in a porcine coronary stent model
K.J. Salu, J.M. Bosmans, H. Bult, Y. Huang, L. Xiaoshun, I. K.  De Scheerder, and C.J. Vrints (Antwerp/Leuven, Belgium)
147
12.05 – 12.30 Drug eluting stents : a definitive solution for restenosis ?
Y. De Scheerder (Leuven, Belgium)		  
12.30    end of workshop 16